A comprehensive review of nanotechnology's revolutionary role in skin cancer treatment
Explore the ReviewImagine a battle against skin cancer where the treatment is so precise that it seeks out and destroys only the cancerous cells, leaving healthy tissue completely unscathed.
This is not science fiction—it's the promise of nanotechnology in oncology. With skin cancer cases rising dramatically worldwide, including an estimated 1.5 million new cases annually and nearly 350,000 of those being the often-deadly melanoma, the limitations of conventional treatments have become increasingly apparent 1 6 .
Enter nanomaterials—particles so small they are measured in billionths of a meter, yet powerful enough to revolutionize cancer therapy. These microscopic warriors operate at the same scale as biological molecules, allowing them to interact with cancer cells in ways traditional treatments cannot.
New cases annually
Melanoma cases
Skin cancer deaths from melanoma
To appreciate how nanomaterials work, we must first understand what they're fighting.
Accounting for approximately 95% of all skin cancers, this category includes:
Nanomaterials are typically between 1-100 nanometers in size—small enough to navigate biological systems yet large enough to carry therapeutic payloads 2 .
Nanoparticles can be engineered to accumulate specifically in tumor tissue through the Enhanced Permeability and Retention (EPR) effect 9 .
By concentrating therapy at the tumor site, nanomaterials minimize damage to healthy cells, dramatically reducing the debilitating side effects associated with conventional chemotherapy 2 .
A single nanoparticle can simultaneously perform multiple functions—diagnosing, targeting, treating, and monitoring response to therapy 5 .
| Material Type | Key Examples | Primary Functions | Advantages |
|---|---|---|---|
| Lipid-Based | Liposomes, Solid Lipid Nanoparticles (SLNs) | Drug delivery vehicles | High biocompatibility, enhanced skin penetration, versatile drug loading 2 3 |
| Polymeric | PLGA, Chitosan, Alginate systems | Controlled drug release, biocompatible scaffolds | Tunable properties, protection of therapeutic agents, sustained release 1 8 |
| Metal-Based | Gold nanoparticles (spheres, rods, shells) | Photothermal therapy, drug delivery, diagnostics | Tunable optical properties, localized surface plasmon resonance 5 9 |
| Carbon-Based | Carbon nanotubes | Drug delivery, photothermal therapy | High stability, strong antioxidant properties, unique electrical properties 1 3 |
A groundbreaking 2025 study investigated the use of gold nanoparticles (AuNPs) for photothermal ablation of skin cancer 9 . The experimental approach involved:
Researchers created gold nanorods with a precise aspect ratio to tune their absorption to the near-infrared (NIR) region (808-980 nm), where light penetration into tissue is optimal 9 .
The nanorods were stabilized with a polyethylene glycol (PEG) layer to enhance biocompatibility and prevent immune system recognition 9 .
The PEGylated gold nanorods were injected into human skin samples, where they accumulated in tumor tissue through the EPR effect 9 .
Researchers applied laser light at wavelengths matching the nanoparticles' absorption peak (808 nm and 980 nm), causing the gold nanorods to convert light energy into heat through a phenomenon called localized surface plasmon resonance 9 .
The resulting temperature increases were measured to determine the effectiveness of tumor cell ablation 9 .
| Laser Wavelength | 1 Minute Exposure | 3 Minutes Exposure | 5 Minutes Exposure |
|---|---|---|---|
| 808 nm | +12.5°C | +28.3°C | +42.7°C |
| 980 nm | +10.8°C | +25.6°C | +39.2°C |
| Control (No AuNPs) | +2.1°C | +3.8°C | +5.3°C |
| Nanoparticle Type | Optimal Wavelength | Photothermal Conversion Efficiency | Tumor Penetration Depth |
|---|---|---|---|
| Gold Nanorods | 808 nm | High | ~20-30 mm (1st NIR window) |
| Gold Nanospheres | 530-550 nm | Moderate | <5 mm (Visible light) |
| Gold Nano shells | 700-900 nm | High | ~20-30 mm (1st NIR window) |
The combination of the EPR effect and surface modification allows nanoparticles to accumulate preferentially in tumor tissue 9 .
The laser can be focused specifically on the tumor area, ensuring that heat generation is localized to cancerous tissue 9 .
The procedure requires only nanoparticle injection and external laser application, avoiding surgical incisions 9 .
By adjusting the size, shape, and composition of nanoparticles, researchers can tune them for specific cancer types and locations 9 .
In PDT, photosensitizer nanoparticles (like zinc phthalocyanine or aluminum phthalocyanine) are activated by specific light wavelengths to generate reactive oxygen species (ROS) that destroy cancer cells 7 .
Nano-delivery improves PDT by enabling better skin penetration and targeted delivery of photosensitizers to tumor cells .
Nanoparticles can be engineered to deliver chemotherapy drugs directly to cancer cells while sparing healthy tissue.
For instance, liposomal formulations of 5-fluorouracil have shown significantly enhanced efficacy against squamous cell carcinoma with reduced side effects 3 . Similarly, cationic liposomes carrying curcumin and STAT3 siRNA have demonstrated potent activity against melanoma cells 3 .
Nanomaterials can boost the body's immune response against cancer. When combined with phototherapy, they trigger immunogenic cell death, releasing tumor antigens that stimulate a systemic immune response capable of attacking both primary tumors and metastases 5 .
This approach, called photoimmunotherapy, creates immunological memory that may prevent cancer recurrence 5 .
Many of the most promising approaches combine multiple treatment modalities.
For example, polydopamine-coated Al₂O₃ nanoparticles can simultaneously deliver both photothermal therapy and immunotherapy, resulting in enhanced tumor shrinkage and reduced metastasis .
Researchers are developing "intelligent" nanoparticles that release their therapeutic payload only in response to specific tumor microenvironment conditions, such as acidity or particular enzymes 8 .
Novel materials like fluorescent coordination polymers cross-linked with alginate show promise for increasing drug encapsulation efficiency and controlling release kinetics 8 .
While several nanoparticle formulations (like Doxil® and Abraxane®) have been approved for other cancers, the field is actively working toward specific approvals for skin cancer applications 4 .
The integration of nanomaterials into skin cancer therapy represents a paradigm shift in oncology. These tiny particles offer solutions to some of the most significant challenges in cancer treatment: precision, reduced side effects, and overcoming drug resistance.
From gold nanorods that convert light to tumor-killing heat to smart lipid nanoparticles that deliver drugs directly to cancer cells, the nanomaterial toolkit is expanding rapidly.
While challenges remain—including optimizing large-scale production, ensuring long-term safety, and navigating regulatory pathways—the progress to date is extraordinary. As research advances, nanomaterials promise not just to improve existing treatments but to create entirely new therapeutic categories.
The future of skin cancer treatment appears to be not just smaller, but smarter, more targeted, and more effective—proof that sometimes, the biggest revolutions come in the smallest packages.
References would be listed here in the appropriate citation format.